溶解性 | DMSO |
存贮条件 | 储存温度-20°C |
产品介绍 | NVP-LCQ195 (AT9311; LCQ195)是CDK杂环类抑制剂,对CDK1,CDK2,CDK3和CDK5的IC50为1-42 nM。 |
生化机理 | NVP-LCQ195 (AT9311; LCQ195) is a small molecule heterocyclic compound which inhibits CDK1, CDK2 and CDK5, as well as CDK3 and CDK9. Cell cycle regulators, such as cyclin-dependent kinases (CDKs), are appealing targets for multiple myeloma (MM) therapy given the increased proliferative rates of tumour cells in advanced versus early stages of MM. NVP-LCQ195 induced cell cycle arrest and eventual apoptotic cell death of MM cells, even at sub-μmol/l concentrations, spared non-malignant cells, and overcame the protection conferred to MM cells by stroma or cytokines of the bone marrow milieu. |
别名 | LCQ-195;AT-9311;NVP LCQ195;LCQ 195;AT9311;AT 9311;4-(2,6-二氯苯甲酰基氨基)-1H-吡唑-3-羧酸 N-[1-(甲基磺酰基)哌啶-4-基]酰胺;LCQ-195;AT-9311;NVP LCQ195;LCQ 195;AT9311;AT 9311;4-(2,6-Dichlorobenzoylamino)-1H-pyrazole-3-carboxylic acid N-[1-(methylsulfonyl)piperidin-4-yl]amide |
NVP-LCQ195,CDK杂环类抑制剂
NVP-LCQ195 (订货以英文为准)
编号:N127100
CAS号:902156-99-4
分子式:C17H19CL2N5O4S
分子量:460.33
产品名称 | NVP-LCQ195 |
中文名称 | NVP-LCQ195,CDK杂环类抑制剂 |
CAS号 | 902156-99-4 |
分子式(M.F.) | C17H19CL2N5O4S |
分子量(M.W.) | 460.33 |
储存条件 | -20°C储存 |
标识符号 | https://www.aladdin-e.com/images/ghs/ghs07.jpg |
信号词 | Warning |
危害声明 | H317-H319 |
警示性声明 | P280-P305 + P351 + P338 |
WGK德国 | 3 |
搜索质检报告(COA)
搜索MSDS
相关产品